The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Real-world treatment patterns among patients with advanced gastric cancer in South Korea.
Gebra Cuyun Carter
Employment or Leadership Position - Lilly
Stock Ownership - Lilly
Anna Kaltenboeck
Research Funding - Lilly
Jasmina Ivanova
Research Funding - Lilly
Astra M. Liepa
Employment or Leadership Position - Lilly
Stock Ownership - Lilly
Alexandra San Roman
Consultant or Advisory Role - Lilly
Maria Koh
No relevant relationships to disclose
Hyun Jung Lee
Employment or Leadership Position - Lilly
Stock Ownership - Lilly
Narayan Rajan
Employment or Leadership Position - Lilly
Stock Ownership - Lilly
Shaila Ballal
Employment or Leadership Position - Lilly
Stock Ownership - Lilly
Howard Birnbaum
Research Funding - Lilly
Yung-Jue Bang
Consultant or Advisory Role - Lilly
Honoraria - Lilly
Research Funding - Lilly